NAICS 541714Research and Development in Biotechnology (except Nanobiotechnology)
The Census Bureau's definition, the SBA size standard that decides who is small under it, and the federal market behind it: what the government spends under 541714, the agencies that buy it, the companies that win it and the notices open under it today.
Federal contract obligations
FY 2022 to FY 2027 so far
Top buying department
USAspending.gov
To small businesses
Share of the obligations
Open notices now
SAM.gov, posted under this code
Official definition
Census Bureau, 2022 NAICS, verbatim.
This U.S. industry comprises establishments primarily engaged in conducting biotechnology (except nanobiotechnology) research and experimental development. Biotechnology (except nanobiotechnology) research and experimental development involves the study of the use of microorganisms and cellular and biomolecular processes to develop or alter living or non-living materials. This research and development in biotechnology (except nanobiotechnology) may result in development of new biotechnology (except nanobiotechnology) processes or in prototypes of new or genetically-altered products that may be reproduced, utilized, or implemented by various industries.
Illustrative Examples:
Cloning research and experimental development laboratories DNA technologies (e.g., microarrays) research and experimental development laboratories Nucleic acid chemistry research and experimental development laboratories Protein engineering research and experimental development laboratories Recombinant DNA research and experimental development laboratories
Illustrative activities (20)
- Biotechnology research and development laboratories or services (except nanobiotechnology research and development)
- Biotechnology research and development laboratories or services in agriculture (except nanobiotechnology research and development)
- Biotechnology research and development laboratories or services in bacteriology (except nanobiotechnology research and development)
- Biotechnology research and development laboratories or services in biology (except nanobiotechnology research and development)
- Biotechnology research and development laboratories or services in botany (except nanobiotechnology research and development)
- Biotechnology research and development laboratories or services in chemical sciences (except nanobiotechnology research and development)
- Biotechnology research and development laboratories or services in entomology (except nanobiotechnology research and development)
- Biotechnology research and development laboratories or services in environmental science (except nanobiotechnology research and development)
- Biotechnology research and development laboratories or services in food science (except nanobiotechnology research and development)
- Biotechnology research and development laboratories or services in genetics (except nanobiotechnology research and development)
- Biotechnology research and development laboratories or services in health sciences (except nanobiotechnology research and development)
- Biotechnology research and development laboratories or services in industrial research (except nanobiotechnology research and development)
- Biotechnology research and development laboratories or services in the medical sciences (except nanobiotechnology research and development)
- Biotechnology research and development laboratories or services in the physical sciences (except nanobiotechnology research and development)
- Biotechnology research and development laboratories or services in the veterinary sciences (except nanobiotechnology research and development)
- Cloning research and experimental development laboratories
- DNA technologies (e.g., microarrays) research and experimental development laboratories
- Nucleic acid chemistry research and experimental development laboratories
- Protein engineering research and experimental development laboratories
- Recombinant DNA research and experimental development laboratories
What the manual classifies elsewhere
- Conducting research and experimental development in nanotechnology (e.g., nanobiotechnology)--are classified in U.S. Industry 541713, Research and Development in Nanotechnology;541713
- Conducting research and experimental development in the physical, engineering, and life sciences (except nanotechnology and biotechnology)--are classified in U.S. Industry 541715, Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology);541715
- Providing physical, chemical, or other analytical testing services (except medical or veterinary), such as acoustics or vibration testing, calibration testing, electrical and electronic testing, geotechnical testing, mechanical testing, nondestructive testing, or thermal testing--are classified in Industry 541380, Testing Laboratories and Services;541380
- Providing veterinary testing services--are classified in Industry 541940, Veterinary Services;541940
- Providing medical laboratory testing for humans--are classified in U.S. Industry 621511, Medical Laboratories;621511
- Raising funds for health related research--are classified in U.S. Industry 813212, Voluntary Health Organizations;813212
- Manufacturing vaccines, toxoids, blood fractions, and culture media of plant or animal origin (except diagnostic use)--are classified in U.S. Industry 325414, Biological Product (except Diagnostic) Manufacturing; and325414
- Manufacturing uncompounded medicinal chemicals and their derivatives (i.e., enzyme proteins and antibiotics for pharmaceutical use)--are classified in U.S. Industry 325411, Medicinal and Botanical Manufacturing.325411
Small business size standard
SBA's rule under 13 C.F.R. 121.201, a different authority from the classification.
In force today. 13 C.F.R. 121.201
Proposed rule, 91 FR 53741 (Aug 20, 2026). Comments closed Nov 20, 2026. Not in force until SBA publishes a final rule.
Read the comments on Regulations.govDocket SBA-2026-0199
SBA OHA appeals that cite it
NAICS designation and size appeals whose caption or digest states this code. OHA dockets by case number rather than by industry, so this is a text match on the published text, not a field the corpus stores.
No OHA decision in the corpus names this code.
Who buys it, who wins it
Prime contract obligations under 541714, FY 2022 to FY 2027 so far, live from USAspending.gov. Companies are summed across their registrations.
Obligations by fiscal year
Obligations by fiscal year could not be read from USAspending.gov just now. Open the code in the dashboard for a live read.
Agencies that buy it
The agencies that buy this code could not be read from USAspending.gov just now. Open the code in the dashboard for a live read.
Who wins it
The companies that win this code could not be read from USAspending.gov just now. Open the code in the dashboard for a live read.
What is bought under it
Product and service codes (PSC) on the awards under this industry.
The product and service codes under this industry could not be read from USAspending.gov just now. Open the code in the dashboard for a live read.
The largest awards under 541714
Award value to date, from USAspending.gov. Each award opens on USAspending.gov.
The largest awards could not be read from USAspending.gov just now. Open the code in the dashboard for a live read.
Open notices under 541714
Contract Opportunities, refreshed daily. Each notice opens on SAM.gov.
- Procurement of prototype phage hygiene spray bottlesSmall Business Set Aside - TotalDue Nov 30, 2026
Department of the Army
- DNA Sequencing ServiceNo set-asideDue Dec 7, 2026
National Institutes of Health
- Simulation-augmented, Real-time Platform Adaptive Seamless Trials (SURPASS)No set-asideDue Nov 30, 2026
National Institutes of Health
- Pre-solicitation Notice: On-Ramp for the Department of Defense OMNIBUS IV Multiple-Award Contract8(a) Set-Aside (FAR 19.8)
Defense Health Agency (DHA)
- FirefoxNo set-asideDue Nov 30, 2026
Defense Advanced Research Projects Agency (DARPA)
Search every award under 541714
Filter the prime awards by keyword, agency, company, set-aside, place of performance and fiscal-year window, and download the list.
Every open notice, filtered
All open SAM.gov notices under the code by set-aside, notice type and agency, searchable by keyword.
Where you stand under 541714
Your own awards under the code, your size under its standard, and the open notices matched to your company.
Related industries
NAICS 541714,
answered.
The size standard, the spending and the buyers under Research and Development in Biotechnology (except Nanobiotechnology), from the figures on this page.
NAICS 541714 is Research and Development in Biotechnology (except Nanobiotechnology) in the 2022 North American Industry Classification System. This U.S. industry comprises establishments primarily engaged in conducting biotechnology (except nanobiotechnology) research and experimental development. Biotechnology (except nanobiotechnology) research and experimental development involves the study of the use of microorganisms and cellular and biomolecular processes to develop or alter living or non-living materials. This research and development in biotechnology (except nanobiotechnology) may result in development of new biotechnology (except nanobiotechnology) processes or in prototypes of new or genetically-altered products that may be reproduced, utilized, or implemented by various industries. Illustrative Examples: Cloning...
The SBA size standard for NAICS 541714 is 1,000 employees under 13 C.F.R. 121.201. SBA has proposed 2,800 employees in 91 FR 53741; the proposal is not in force until SBA publishes a final rule.
Work the market under 541714
Rank the buyers and the partners under this code, search its awards and notices, and see where your company stands. Monthly Pro starts with a 14-day free trial.
Sources: U.S. Census Bureau, 2022 NAICS; 13 C.F.R. 121.201; USAspending.gov; SAM.gov Contract Opportunities; SBA Office of Hearings and Appeals. Figures refresh daily. A code and a size standard shown here are research, not a size determination or a NAICS code designation, which only SBA and the contracting officer make. A company or agency listed here is not an endorsement.